Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Mott

Showing results (231-240 of 254) with videos related to

Pageof 26
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 10, 2020
Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor ModelsSteven N Seyedin, M M Hasibuzzaman, Vivan Pham, et al.
Blood Cancer Journal|November 21, 2021
A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome predictionKalyan Nadiminti, Kimberly Langer, Ehsan Shabbir, et al.
Translational Lung Cancer Research|September 29, 2021
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a <i>STK11</i> mutationJosiah An, Melissa Yan, Nanmeng Yu, et al.
Gastroenterology|March 11, 2009
Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell linesYuko Akazawa, Justin L Mott, Steven F Bronk, et al.
BJU International|May 28, 2026
Computed tomography-derived extracellular volume fraction is associated with high-grade recurrence in non-muscle-invasive bladder cancer treated with intravesical gemcitabine and docetaxelMohamad Abou Chakra, Issa Alsamarah, Helen Y Hougen, et al.
Molecular Pharmaceutics|July 19, 2019
Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic MelanomaMengshi Li, Dijie Liu, Dongyoul Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell CarcinomaYousef Zakharia, Ryan J Reis, Matthew R Kroll, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2018
<sup>90</sup>Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide TherapyYusuf Menda, Mark T Madsen, Thomas M O'Dorisio, et al.
Pancreas|August 10, 2020
Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography-Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine TumorsSilvia N Ghobrial, Yusuf Menda, Gideon K Zamba, et al.
Scientific Reports|May 14, 2021
Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasisCourtney A Kaemmer, Shaikamjad Umesalma, Chandra K Maharjan, et al.
Pageof 26

Showing results (231-240 of 254) with videos related to

Sort By:
Pageof 26
International Journal of Radiation Oncology, Biology, Physics|February 10, 2020
Combination Therapy with Radiation and PARP Inhibition Enhances Responsiveness to Anti-PD-1 Therapy in Colorectal Tumor ModelsSteven N Seyedin, M M Hasibuzzaman, Vivan Pham, et al.
Blood Cancer Journal|November 21, 2021
A novel Iowa-Mayo validated composite risk assessment tool for allogeneic stem cell transplantation survival outcome predictionKalyan Nadiminti, Kimberly Langer, Ehsan Shabbir, et al.
Translational Lung Cancer Research|September 29, 2021
Outcomes of patients with stage III non-small cell lung cancer (NSCLC) that harbor a <i>STK11</i> mutationJosiah An, Melissa Yan, Nanmeng Yu, et al.
Gastroenterology|March 11, 2009
Death receptor 5 internalization is required for lysosomal permeabilization by TRAIL in malignant liver cell linesYuko Akazawa, Justin L Mott, Steven F Bronk, et al.
BJU International|May 28, 2026
Computed tomography-derived extracellular volume fraction is associated with high-grade recurrence in non-muscle-invasive bladder cancer treated with intravesical gemcitabine and docetaxelMohamad Abou Chakra, Issa Alsamarah, Helen Y Hougen, et al.
Molecular Pharmaceutics|July 19, 2019
Enhancing the Efficacy of Melanocortin 1 Receptor-Targeted Radiotherapy by Pharmacologically Upregulating the Receptor in Metastatic MelanomaMengshi Li, Dijie Liu, Dongyoul Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 29, 2025
Phase I Clinical Trial of High Doses of Seleno-L-methionine in Combination with Axitinib in Patients with Previously Treated Metastatic Clear-cell Renal Cell CarcinomaYousef Zakharia, Ryan J Reis, Matthew R Kroll, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 11, 2018
<sup>90</sup>Y-DOTATOC Dosimetry-Based Personalized Peptide Receptor Radionuclide TherapyYusuf Menda, Mark T Madsen, Thomas M O'Dorisio, et al.
Pancreas|August 10, 2020
Prospective Analysis of the Impact of 68Ga-DOTATOC Positron Emission Tomography-Computerized Axial Tomography on Management of Pancreatic and Small Bowel Neuroendocrine TumorsSilvia N Ghobrial, Yusuf Menda, Gideon K Zamba, et al.
Scientific Reports|May 14, 2021
Development and comparison of novel bioluminescent mouse models of pancreatic neuroendocrine neoplasm metastasisCourtney A Kaemmer, Shaikamjad Umesalma, Chandra K Maharjan, et al.
Pageof 26